Cargando…
Brain injury clinical trials: new agents or new statistics?
Failure of the vast majority of clinical trials evaluating recovery after severe brain injury from stroke or trauma has triggered interest in novel statistical techniques that are more powerful than conventional dichotomized outcomes. A retrospective analysis of data from a large international trial...
Autores principales: | Willey, Joshua Z, Mayer, Stephan A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334732/ https://www.ncbi.nlm.nih.gov/pubmed/21978461 http://dx.doi.org/10.1186/cc10350 |
Ejemplares similares
-
Statistical consideration when adding new arms to ongoing clinical trials: the potentials and the caveats
por: Lee, Kim May, et al.
Publicado: (2021) -
Can a simple blood test quantify brain injury?
por: Mayer, Stephan A, et al.
Publicado: (2009) -
Melanoma: A model for testing new agents in combination therapies
por: Ascierto, Paolo A, et al.
Publicado: (2010) -
Speeding up the Evaluation of New Agents in Cancer
por: Parmar, Mahesh K. B., et al.
Publicado: (2008) -
New tricks with old dogs: personalised medicine and clinical trials
por: Koziol, J A
Publicado: (2011)